Thomas Mertens
Impact in
- Parasitology top 2%
- Toxoplasma gondii Research Studies
- Epidemiology top 2%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
Papers in
- Epidemiology 54
- Cytomegalovirus and herpesvirus research 43
- Herpesvirus Infections and Treatments 29
- Parasitology 10
- Toxoplasma gondii Research Studies 9
- Co-authors
- Giada FrascaroliPaul WaltherJens von EinemDetlef MichelLutz von MüllerMeike DittmannChristopher BuserAxel Schubert
- Journals
- Journal of Virology (14 papers)Antimicrobial Agents and Chemotherapy (4 papers)Vaccine (3 papers)The Journal of Immunology (3 papers)Journal of General Virology (3 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Thomas Mertens
72 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 114
- Parasitology 274
- Epidemiology 1.4k
- Virology 134
- Immunology 586
- Infectious Diseases 250
Countries citing papers authored by Thomas Mertens
This map shows the geographic impact of Thomas Mertens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mertens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mertens more than expected).
Fields of papers citing papers by Thomas Mertens
This network shows the impact of papers produced by Thomas Mertens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mertens. The network helps show where Thomas Mertens may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Mertens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | Market Assessment of COVID-19 | 2020 | 15 |
| 3 | 2020 | 8 | |
| 4 | Average-Inflation Targeting and the Effective Lower Bound | 2020 | 3 |
| 5 | 2019 | 12 | |
| 6 | 2018 | 26 | |
| 7 | 2013 | 26 | |
| 8 | 2013 | 5 | |
| 9 | Mens & mensenrechten. Basisboek rechtsfilosofie | 2012 | 0 |
| 10 | 2011 | 10 | |
| 11 | 2010 | 23 | |
| 12 | 2009 | 58 | |
| 13 | 2009 | 64 | |
| 14 | 2008 | 14 | |
| 15 | 2007 | 58 | |
| 16 | 2006 | 14 | |
| 17 | 2002 | 75 | |
| 18 | 2001 | 17 | |
| 19 | [Risk factors in prematurity and intrauterine growth retardation in Burkina Faso]. | 1995 | 12 |
| 20 | 1992 | 24 |
About Thomas Mertens
Thomas Mertens is a scholar working on Epidemiology, Parasitology, Virology, Immunology and Health, having authored 75 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (43 papers), Herpesvirus Infections and Treatments (29 papers), Immune Cell Function and Interaction (10 papers), Toxoplasma gondii Research Studies (9 papers), T-cell and B-cell Immunology (7 papers), Virus-based gene therapy research (5 papers), Animal Virus Infections Studies (5 papers) and Vaccine Coverage and Hesitancy (5 papers). The work is most often cited by research in Parasitology (274 citations), Epidemiology (1.4k citations), Virology (134 citations), Immunology (586 citations) and Infectious Diseases (250 citations). Thomas Mertens has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Giada Frascaroli, Paul Walther, Jens von Einem, Detlef Michel, Lutz von Müller, Meike Dittmann, Christopher Buser, Axel Schubert, Zeguang Wu and Michael Winkler. Their work appears in journals such as Journal of Virology, Antimicrobial Agents and Chemotherapy, Vaccine, The Journal of Immunology and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.